Ledger.Open graph →
SEC Form D · filed October 20, 2022

Vita Therapeutics, Inc

Offering
$30.9M
Sold
$30.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Mark Nuttall · Baltimore, MDDirectorVlad Coric · New Haven, CTDirectorJames Peyer · NOVATO, CADirectorEva Chin · Baltimore, MDDirectorMark Nuttall · Baltimore, MDDirectorDavid Churchill · Baltimore, MDDirectorJames Peyer · NOVATO, CADirectorDavid Churchill · Atlanta, GADirectorVlad Coric · New Haven, CTDirectorDouglas Falk · Baltimore, MDExec · DirectorEva Chin · Baltimore, MDDirectorDavid Churchill · Baltimore, MDDirectorDouglas Falk · Baltimore, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗